According to the Digest`s Editorial office opinion, the main events of the October 2022 in Russian pharmaceutical industry are:
- since February of this year, not a single foreign pharmaceutical company has left the Russian market;
- analysts have predicted the growth of the Russian pharmaceutical market by the end of 2022 up to 47 billion USD;
- The President of Russia approved the law on prescription medicines online-trading;
- in the eastern region of Russia, experts found fake veterinary medicines;
- one of the largest Russian distributors lost a lawsuit against Johnson & Johnson for 6.5 million USD.
These, as well all other industry month news, are in the October 2022 issue (Russian edition) of the Digest.
Natalia Egorova, Editor-in-Chief01.11.2022.